These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 7260006)

  • 1. The effect of menopausal status and sequential mestranol and norethisterone on serum biochemical profiles.
    Moore B; Paterson ME; Sturdee DW; Whitehead TP
    Br J Obstet Gynaecol; 1981 Aug; 88(8):853-8. PubMed ID: 7260006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of menopausal status and sequential mestranol and norethisterone on serum cholesterol, triglyceride and electrophoretic lipoprotein patterns.
    Paterson ME; Sturdee DW; Moore B; Whitehead TP
    Br J Obstet Gynaecol; 1979 Oct; 86(10):810-5. PubMed ID: 508663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of sequential mestranol-norethisterone on the circulating lipid levels of pre- and post-menopausal women, and its possible significance.
    Magnani HN; Moore B
    Postgrad Med J; 1976; 52 Suppl 6():55-9. PubMed ID: 981121
    [No Abstract]   [Full Text] [Related]  

  • 4. The effect of various regimens of hormone therapy on serum cholesterol and triglyceride concentrations in postmenopausal women.
    Paterson ME; Sturdee DW; Moore B; Whitehead TP
    Br J Obstet Gynaecol; 1980 Jul; 87(7):552-60. PubMed ID: 6252948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of bone mineral loss in postmenopausal women by norethisterone.
    Abdalla HI; Hart DM; Lindsay R; Leggate I; Hooke A
    Obstet Gynecol; 1985 Dec; 66(6):789-92. PubMed ID: 4069480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomised, double-blind, cross-over study into the effect of sequential mestranol and norethisterone on climacteric symptoms and biochemical parameters.
    Paterson ME
    Maturitas; 1982 Aug; 4(2):83-94. PubMed ID: 6750325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of hormone replacement therapy on glucose tolerance in postmenopausal women.
    Thom M; Chakravarti S; Oram DH; Studd JW
    Br J Obstet Gynaecol; 1977 Oct; 84(10):776-83. PubMed ID: 200256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma protein changes in post-menopausal women receiving mestranol-norethisterone hormone replacement therapy.
    Burnett D; Moore B; Williams JG; Studd JW; Bradwell AR
    Postgrad Med J; 1976; 52 Suppl 6():48-51. PubMed ID: 981119
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison of metabolic and clinical effects of four oral contraceptive formulations and a contraceptive vaginal ring.
    Roy S; Mishell DR; Gray G; Dozono-Takano R; Brenner PF; Eide I; de Quattro V; Shaw ST
    Am J Obstet Gynecol; 1980 Apr; 136(7):920-31. PubMed ID: 6767404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in the bone and liver isoenzymes of alkaline phosphatase in postmenopausal women being treated with norethisterone.
    Deeny M; Farish E; Tillman J; Dagen M; Hart DM; Fletcher CD
    Clin Chim Acta; 1988 Jan; 171(1):103-8. PubMed ID: 3349632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects on sex hormone binding globulin of different oral contraceptives containing norethisterone and lynestrenol.
    Odlind V; Weiner E; Victor A; Johansson ED
    Br J Obstet Gynaecol; 1980 May; 87(5):416-21. PubMed ID: 6155933
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Liver function studies under the influence of hormonal contraceptives (sequential preparations)].
    Brügmann E; Göretzlehner G; Dabels J; Töwe J
    Dtsch Z Verdau Stoffwechselkr; 1979; 39(2):69-74. PubMed ID: 88322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of the climacteric and sequential mestranol and norethisterone on the cervix and genital tract.
    Paterson ME; Allen J; Jordan JA
    Br J Obstet Gynaecol; 1982 Aug; 89(8):657-64. PubMed ID: 7104258
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Liver function tests under the influence of sequential treatment using ethinyl estradiol-norethisterone acetate and ethinyl estradiol-chlormadinone acetate].
    Akpowowo HE; Göretzlehner G; Brügmann E; Töwe J
    Zentralbl Gynakol; 1976; 98(19):1198-203. PubMed ID: 62469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patterns of change for various biochemical constituents detected in well population screening.
    Wilding P; Rollason JG; Robinson D
    Clin Chim Acta; 1972 Oct; 41():375-87. PubMed ID: 4645246
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of norethisterone on pressor response to angiotensin II in men.
    Mabe K; Ito M; Okamura H
    Obstet Gynecol; 1992 Aug; 80(2):291-5. PubMed ID: 1635747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of estrogen and progesterone on plasma platelet-activating factor-acetylhydrolase activity and low-density lipoprotein cholesterol concentration in men.
    Ohshige A; Ito M; Koyama H; Maeda T; Yoshimura T; Okamura H
    Artery; 1996; 22(3):115-24. PubMed ID: 8893970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum biochemical values in rheumatoid disease.
    Cockel R; Kendall MJ; Becker JF; Hawkins CF
    Ann Rheum Dis; 1971 Mar; 30(2):166-70. PubMed ID: 5569437
    [No Abstract]   [Full Text] [Related]  

  • 19. Oral contraceptives, norethindrone and mestranol: effects on tissue levels of minerals.
    Lei KY; Prasad AS; Bowersox E; Oberleas D
    Am J Physiol; 1976 Jul; 231(1):98-103. PubMed ID: 961877
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The redistribution of body sodium in women on long-term oestrogen therapy.
    Aitken JM; Lindsay R; Hart DM
    Clin Sci Mol Med; 1974 Aug; 47(2):179-87. PubMed ID: 4607230
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.